#	Pagina
attuale pagina	/open-h2020/projects/216961/index.html
-1	/open-h2020/per-topic/zanato/list/index.html
-2	/open-h2020/per-topic/biotextiles/list/index.html
-3	/open-h2020/per-topic/donors/list/index.html
-4	/open-h2020/per-topic/treponema/list/index.html
-5	/open-h2020/per-topic/attodna/list/index.html
-6	/open-h2020/per-topic/anthology/list/index.html
-7	/open-h2020/per-topic/rug/list/index.html
-8	/open-h2020/per-topic/retopea/list/index.html

Opendata, web and dolomites

ReSOLUTE SIGNED

Research empowerment on solute carriers (ReSOLUTE)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Outcomes and
results

ReSOLUTE project word cloud

Explore the words cloud of the ReSOLUTE project. It provides you a very rough idea of what is the project "ReSOLUTE" about.

worldwide group medizinische forschung genetic central solute members bayer novartis expertise veloppement intensity grade axxam seven coupling data planck gene suitability boehringer family oxford class generation transform acceleration redundant sanofi resolute prioritized networks antibodies academic repositories establishing manner carriers accessed et genomic lines time six merges inducing drug network landscape tractable list eacute engineering pharma knowledgebase cemm cell aventis pfizer deorphanisation complementary binders uk slcs affinity collection proteomics formats industrial slc assay leiden hardware connections functional core industry variety empowerment parallel interlinked spa super proteins plan ingelheim univ sme limited recherche elected decisive uuml ag standards certain omics max institut validated strategy systematically goals systematic metabolomics manchester wien tools datasets combining vifor cover

Project "ReSOLUTE" data sheet

The following table provides information about the project.

Coordinator	CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH Organization address address: LAZARETTGASSE 14 AKH BT 25.3 city: WIEN postcode: 1090 website: http://www.oeaw.ac.at/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Austria [AT]
Project website	https://re-solute.eu/
Total cost	23˙850˙000 €
EC max contribution	12˙000˙000 € (50%)
Programme	1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
Code Call	H2020-JTI-IMI2-2016-10-two-stage
Funding Scheme	IMI2-RIA
Starting year	2018
Duration (year-month-day)	from 2018-07-01 to 2023-06-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH Organization address address: LAZARETTGASSE 14 AKH BT 25.3 city: WIEN postcode: 1090 website: http://www.oeaw.ac.at/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (WIEN)	coordinator	6˙841˙011.00
2	THE UNIVERSITY OF LIVERPOOL THE UNIVERSITY OF LIVERPOOL Organization address address: BROWNLOW HILL 765 FOUNDATION BUILDING city: LIVERPOOL postcode: L69 7ZX website: www.liverpool.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LIVERPOOL)	participant	1˙220˙266.00
3	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD Organization address address: WELLINGTON SQUARE UNIVERSITY OFFICES city: OXFORD postcode: OX1 2JD website: www.ox.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (OXFORD)	participant	1˙208˙850.00
4	AXXAM SPA AXXAM SPA Organization address address: VIA MEUCCI 3 city: BRESSO MILANO postcode: 20091 website: www.axxam.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (BRESSO MILANO)	participant	1˙141˙250.00
5	UNIVERSITEIT LEIDEN UNIVERSITEIT LEIDEN Organization address address: RAPENBURG 70 city: LEIDEN postcode: 2311 EZ website: www.universiteitleiden.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (LEIDEN)	participant	723˙588.00
6	MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV Organization address address: HOFGARTENSTRASSE 8 city: MUENCHEN postcode: 80539 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUENCHEN)	participant	483˙750.00
7	UNIVERSITAT WIEN UNIVERSITAT WIEN Organization address address: UNIVERSITATSRING 1 city: WIEN postcode: 1010 website: www.univie.ac.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (WIEN)	participant	379˙812.00
8	THE UNIVERSITY OF MANCHESTER THE UNIVERSITY OF MANCHESTER Organization address address: OXFORD ROAD city: MANCHESTER postcode: M13 9PL website: www.manchester.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (MANCHESTER)	participant	1˙470.00
9	BAYER AKTIENGESELLSCHAFT BAYER AKTIENGESELLSCHAFT Organization address address: KAISER-WILHEM-ALLEE 1 city: Leverkusen postcode: 51373 website: http://pharma.bayer.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (Leverkusen)	participant	0.00
10	BOEHRINGER INGELHEIM INTERNATIONALGMBH BOEHRINGER INGELHEIM INTERNATIONALGMBH Organization address address: BINGER STRASSE city: INGELHEIM postcode: 55218 website: www.boehringerâ€ingelheim.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (INGELHEIM)	participant	0.00
11	NOVARTIS PHARMA AG NOVARTIS PHARMA AG Organization address address: LICHTSTRASSE 35 city: BASEL postcode: 4056 website: www.novartis.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (BASEL)	participant	0.00
12	PFIZER LIMITED PFIZER LIMITED Organization address address: RAMSGATE ROAD city: SANDWICH postcode: CT13 9NJ website: www.pfizer.co.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (SANDWICH)	participant	0.00
13	SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT Organization address address: Pierre Brossolette 1 city: Chilly Mazarin postcode: 91380 website: www.sanofi-aventis.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (Chilly Mazarin)	participant	0.00
14	VIFOR (INTERNATIONAL) AG VIFOR (INTERNATIONAL) AG Organization address address: RECHENSTRASSE 37 city: ST GALLEN postcode: 9014 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (ST GALLEN)	participant	0.00

Map

Project objective

The Research empowerment on solute carriers (ReSOLUTE) proposal aims at inducing a decisive acceleration in the intensity of SLC research worldwide while establishing solute carriers (SLCs) as a tractable target class. It is composed of a core consortium of seven academic/SME members (CeMM, Univ. of Oxford, Univ. of Manchester, AXXAM Spa, Univ. Leiden, Max-Planck Institut für medizinische Forschung, Univ. Wien) and six industrial partners (Pfizer Limited UK, Novartis Pharma AG, Boehringer-Ingelheim, Vifor Pharma Group, Sanofi Aventis Recherche et Développement, Bayer AG) with established and complementary expertise combining industry grade standards and systems level principle-driven analysis.

ReSOLUTE merges systematic and focused approaches: 1) the generation of reliable and validated ‘hardware’ such as cell lines, proteins, antibodies/high affinity binders and large ‘omics’ datasets, 2) a central deorphanisation process coupling genomic engineering to metabolomics and supported by genetic and proteomics studies, 3) a non-redundant process to test systematically the suitability of a certain SLC to a variety of assay formats, 4) a collection of interlinked networks that cover different expertise, datasets and functional connections among SLCs, integrated into large-scale data repositories and a dedicated knowledgebase. The ReSOLUTE strategy will be applied in parallel at the super-family level and, in a more in-depth manner, to a prioritized gene list elected to be potential drug targets. To implement this and achieve the expected goals, the consortium is supported by a large network of academic and industrial partners with specific knowledge of certain SLCs and tools, willing to be accessed at any time and provide specific expertise. Together with a strong dissemination and exploitation plan, we therefore expect that ReSOLUTE will transform the landscape of SLC research for years to come.

Deliverables

List of deliverables.
ReSOLUTE knowledgebase	Documents, reports	2020-04-14 17:13:23
ReSOLUTE database	Websites, patent fillings, videos etc.	2020-04-14 17:13:23
Data Management Plan 1	Documents, reports	2020-04-14 17:13:23
Data Mining	Documents, reports	2020-04-14 17:13:23
Vector generation	Documents, reports	2020-04-14 17:13:23

Take a look to the deliverables list in detail: detailed list of ReSOLUTE deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RESOLUTE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RESOLUTE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

VITAL (2019)

Vaccines and Infectious Diseases in the Ageing PopuLation

Read More

PD-MIND (2019)

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Read More

NEURONET (2019)

Efficiently Networking European Neurodegeneration Research

Read More